Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elvucitabine vs Lamivudine in HIV-1 with M184V
NCT00405249Phase 2Completed
- Sponsor
- Thomas Jefferson University
- Start
- Sep 2006
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of elvucitabine in human immunodeficiency virus infection (HIV), sponsored by Thomas Jefferson University. Started Sep 2006; status: completed.
02
Drugs
elvucitabine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00405249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00405249.